JP2015518007A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015518007A5 JP2015518007A5 JP2015514283A JP2015514283A JP2015518007A5 JP 2015518007 A5 JP2015518007 A5 JP 2015518007A5 JP 2015514283 A JP2015514283 A JP 2015514283A JP 2015514283 A JP2015514283 A JP 2015514283A JP 2015518007 A5 JP2015518007 A5 JP 2015518007A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- schedosporum
- schedospodium
- prolifenicus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 208000015181 infectious disease Diseases 0.000 claims 3
- CCEVJKZHAJJQJR-UHFFFAOYSA-N 5-(2-nitroprop-1-enyl)-1,3-benzodioxole Chemical compound [O-][N+](=O)C(C)=CC1=CC=C2OCOC2=C1 CCEVJKZHAJJQJR-UHFFFAOYSA-N 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 claims 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 claims 1
- MQHLMHIZUIDKOO-OKZBNKHCSA-N (2R,6S)-2,6-dimethyl-4-[(2S)-2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine Chemical compound C1=CC(C(C)(C)CC)=CC=C1C[C@H](C)CN1C[C@@H](C)O[C@@H](C)C1 MQHLMHIZUIDKOO-OKZBNKHCSA-N 0.000 claims 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 claims 1
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 claims 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 claims 1
- 239000005711 Benzoic acid Substances 0.000 claims 1
- 108010020326 Caspofungin Proteins 0.000 claims 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 claims 1
- 108010049047 Echinocandins Proteins 0.000 claims 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 claims 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 229960003204 amorolfine Drugs 0.000 claims 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims 1
- 229960003942 amphotericin b Drugs 0.000 claims 1
- 235000010233 benzoic acid Nutrition 0.000 claims 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 claims 1
- JYIKNQVWKBUSNH-WVDDFWQHSA-N caspofungin Chemical compound C1([C@H](O)[C@@H](O)[C@H]2C(=O)N[C@H](C(=O)N3CC[C@H](O)[C@H]3C(=O)N[C@H](NCCN)[C@H](O)C[C@@H](C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N2)[C@@H](C)O)=O)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@H](O)CCN)=CC=C(O)C=C1 JYIKNQVWKBUSNH-WVDDFWQHSA-N 0.000 claims 1
- 229960003034 caspofungin Drugs 0.000 claims 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 claims 1
- 229960004022 clotrimazole Drugs 0.000 claims 1
- 239000013078 crystal Substances 0.000 claims 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 claims 1
- 229960004884 fluconazole Drugs 0.000 claims 1
- XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 claims 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 claims 1
- 229960002867 griseofulvin Drugs 0.000 claims 1
- 150000002460 imidazoles Chemical class 0.000 claims 1
- 229960004130 itraconazole Drugs 0.000 claims 1
- 229960004125 ketoconazole Drugs 0.000 claims 1
- 229960000988 nystatin Drugs 0.000 claims 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 claims 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 claims 1
- 229960002722 terbinafine Drugs 0.000 claims 1
- 229960002703 undecylenic acid Drugs 0.000 claims 1
- BCEHBSKCWLPMDN-MGPLVRAMSA-N voriconazole Chemical compound C1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)=NC=NC=C1F BCEHBSKCWLPMDN-MGPLVRAMSA-N 0.000 claims 1
- 229960004740 voriconazole Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012902243 | 2012-05-30 | ||
| AU2012902243A AU2012902243A0 (en) | 2012-05-30 | Method of treating Seedosporium spp. infection | |
| PCT/AU2013/000487 WO2013177608A1 (en) | 2012-05-30 | 2013-05-13 | Method of treating scedosporium spp. infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015518007A JP2015518007A (ja) | 2015-06-25 |
| JP2015518007A5 true JP2015518007A5 (OSRAM) | 2016-06-30 |
Family
ID=49672167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015514283A Pending JP2015518007A (ja) | 2012-05-30 | 2013-05-13 | スケドスポリウム属感染症の治療方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9867802B2 (OSRAM) |
| EP (1) | EP2854799B1 (OSRAM) |
| JP (1) | JP2015518007A (OSRAM) |
| CN (1) | CN104519882A (OSRAM) |
| AU (2) | AU2013204604B2 (OSRAM) |
| CA (1) | CA2874881A1 (OSRAM) |
| SG (1) | SG11201407924RA (OSRAM) |
| WO (1) | WO2013177608A1 (OSRAM) |
| ZA (1) | ZA201408975B (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3661496A4 (en) * | 2017-08-01 | 2021-04-21 | Opal Biosciences Limited | TREATMENT OF STAPHYLOCOCCAL AND ENTEROCOCCAL INFECTIONS WITH SUBSTITUTED NITROSTYRENE COMPOUNDS |
| WO2020097398A1 (en) | 2018-11-07 | 2020-05-14 | Dana-Farber Cancer Institute, Inc. | Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof |
| CA3181537A1 (en) | 2020-05-06 | 2021-11-11 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
| WO2022140527A1 (en) | 2020-12-23 | 2022-06-30 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
| CA3234638A1 (en) | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
| TW202325289A (zh) | 2021-11-09 | 2023-07-01 | 美商雅捷可斯治療公司 | Jak2抑制劑之形式及組合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3985761A (en) * | 1974-10-24 | 1976-10-12 | Sarabhai Research Centre | Nitrothiazolyl derivatives of nitrostyrene |
| JPS585902B2 (ja) * | 1978-09-01 | 1983-02-02 | 株式会社大塚製薬工場 | β↓−ニトロスチレン誘導体 |
| RU2259825C9 (ru) * | 2001-06-18 | 2006-04-10 | БиоДием Лимитед | Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности |
| AU2006306690A1 (en) * | 2005-10-24 | 2007-05-03 | Staval Pharma, Ltd. | Method for treating/controlling/killing fungi and bacteria |
| US20080220103A1 (en) * | 2005-10-24 | 2008-09-11 | Jay Birnbaum | Method for treating/controlling/killing fungi and bacteria on living animals |
| WO2008061308A1 (en) * | 2006-11-22 | 2008-05-29 | Biodiem Ltd | Protein tyrosine phosphatase modulators |
| WO2009132342A1 (en) * | 2008-04-25 | 2009-10-29 | Nanobio Corporation | Nanoemulsions for treating fungal, yeast and mold infections |
| UA107963C2 (xx) * | 2010-06-07 | 2015-03-10 | Janssen Pharmaceutica Nv | ПРОТИГРИБКОВІ ПОХІДНІ 5,6-ДИГІДРО-4-$(ДИФТОРЕТИЛ)ФЕНІЛ]-4H-ПІРОЛО$1,2-a]$1,4]БЕНЗОДІАЗЕПІНУ І 4-(ДИФТОРЕТИЛ)ФЕНІЛ-6H-ПІРОЛО$1,2-a]$1,4]БЕНЗОДІАЗЕПІНУ |
-
2013
- 2013-04-12 AU AU2013204604A patent/AU2013204604B2/en not_active Ceased
- 2013-05-13 WO PCT/AU2013/000487 patent/WO2013177608A1/en not_active Ceased
- 2013-05-13 CN CN201380029050.6A patent/CN104519882A/zh active Pending
- 2013-05-13 CA CA2874881A patent/CA2874881A1/en not_active Abandoned
- 2013-05-13 SG SG11201407924RA patent/SG11201407924RA/en unknown
- 2013-05-13 US US14/404,851 patent/US9867802B2/en not_active Expired - Fee Related
- 2013-05-13 EP EP13798071.0A patent/EP2854799B1/en not_active Not-in-force
- 2013-05-13 AU AU2013270430A patent/AU2013270430A1/en not_active Abandoned
- 2013-05-13 JP JP2015514283A patent/JP2015518007A/ja active Pending
-
2014
- 2014-12-05 ZA ZA2014/08975A patent/ZA201408975B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015518007A5 (OSRAM) | ||
| ES2557303T3 (es) | Agente terapéutico para la estenosis del canal espinal | |
| JP2016034978A5 (OSRAM) | ||
| HUE043540T2 (hu) | Szubsztituált dimer kinazolin-származék, elõállítása, valamint alkalmazása 1-es és 2-es típusú cukorbetegség kezelésére szolgáló gyógyászati készítményekben | |
| JP2012255026A5 (OSRAM) | ||
| JP2010222367A5 (OSRAM) | ||
| JP2015523407A5 (OSRAM) | ||
| JP2012501986A5 (OSRAM) | ||
| JP2011516477A5 (OSRAM) | ||
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| JP2017515840A5 (OSRAM) | ||
| JP2013538853A5 (OSRAM) | ||
| JP2016540000A5 (OSRAM) | ||
| JP2014062109A5 (OSRAM) | ||
| JP2007119497A5 (OSRAM) | ||
| UY31790A (es) | Utilización de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia y que tienen un incremento del nivel de creatinina debido a la administración de dronedarona | |
| JP2015516452A5 (OSRAM) | ||
| JP2016540799A5 (OSRAM) | ||
| JP2014530847A5 (OSRAM) | ||
| JP2013541582A5 (OSRAM) | ||
| JP2010526884A5 (OSRAM) | ||
| JP2015516450A5 (OSRAM) | ||
| JP2014162761A5 (OSRAM) | ||
| JP2018513175A5 (OSRAM) | ||
| EA201590732A1 (ru) | Диспергируемая таблетка |